Delivery Order SPE2DB22D9112-SPE2DB25FTKPG
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order, with an ultimate completion date of September 3, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on August 8, 2025. The contract, with an ultimate completion date of August 11, 2025, provides for the delivery of Jakafi 10 mg tablets (60-count units) under a firm fixed-price arrangement. This delivery order was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 7, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025, with performance to be executed in Park Ridge, Illinois. The award represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Jakafi 5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis leveraging its established...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,191.59 by the Defense Logistics Agency on May 30, 2025, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, which carries an ultimate completion date of June 2, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $60.6K by the Defense Logistics Agency on August 18, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order carries an ultimate completion date of August 19, 2025, and was awarded without a set-aside designation. The award was issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,146.79 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Jakafi 5 mg tablets (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $24.0K firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the supply of Jakafi 15 mg tablets (60-count units). The delivery order is expected to be completed by September 4, 2025, with performance taking place at the contractor's Park Ridge facility. This award carries no set-aside designation, allowing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 by the Defense Logistics Agency on August 12, 2025, for the supply of Jakafi 10 mg tablets (60-count). This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 13, 2025. The award represents a task order under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,462.60 by the Defense Logistics Agency on July 11, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 14, 2025, was issued without a set-aside designation. The contract is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKPGDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,231.30 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order is expected to be completed by July 31, 2025, and represents a continuation of the company's significant role as a federal pharmaceutical supplier. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive standing in open federal procurement markets. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026. The underlying IDC enables the DLA to procure a comprehensive portfolio of pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical vendor within the federal pharmaceutical supply chain, with a consistent track record of delivering specialized medical products ranging from oncology treatments to vaccines and contraceptive devices to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 7/30/25 |